null - FindTrial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080225192

Enrollment

360

Registered

2020-05-15

Start date

2020-05-22

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : INN of investigational material : Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine Therapeutic category code :

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

Measure	Time frame
exploratory efficacy efficacy exploratory efficacy exploratory efficacy exploratory exploratory efficacy safety exploratory safety exploratory safety exploratory safety exploratory	—

Primary

Measure	Time frame
efficacy confirmatory	—

Countries

Japan

Outcome results